220 related articles for article (PubMed ID: 37885890)
1.
Ihedioha OC; Sivakoses A; Beverley SM; McMahon-Pratt D; Bothwell ALM
Front Immunol; 2023; 14():1257046. PubMed ID: 37885890
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
3.
Lázaro-Souza M; Matte C; Lima JB; Arango Duque G; Quintela-Carvalho G; de Carvalho Vivarini Á; Moura-Pontes S; Figueira CP; Jesus-Santos FH; Gazos Lopes U; Farias LP; Araújo-Santos T; Descoteaux A; Borges VM
Front Microbiol; 2018; 9():626. PubMed ID: 29675001
[TBL] [Abstract][Full Text] [Related]
4. Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells.
Favila MA; Geraci NS; Jayakumar A; Hickerson S; Mostrom J; Turco SJ; Beverley SM; McDowell MA
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004238. PubMed ID: 26630499
[TBL] [Abstract][Full Text] [Related]
5. Leishmania infantum lipophosphoglycan induced-Prostaglandin E
Lima JB; Araújo-Santos T; Lázaro-Souza M; Carneiro AB; Ibraim IC; Jesus-Santos FH; Luz NF; Pontes SM; Entringer PF; Descoteaux A; Bozza PT; Soares RP; Borges VM
Sci Rep; 2017 Oct; 7(1):14321. PubMed ID: 29084985
[TBL] [Abstract][Full Text] [Related]
6. Binding of Leishmania infantum Lipophosphoglycan to the Midgut Is Not Sufficient To Define Vector Competence in
Coutinho-Abreu IV; Oristian J; de Castro W; Wilson TR; Meneses C; Soares RP; Borges VM; Descoteaux A; Kamhawi S; Valenzuela JG
mSphere; 2020 Sep; 5(5):. PubMed ID: 32907950
[TBL] [Abstract][Full Text] [Related]
7. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2.
Becker I; Salaiza N; Aguirre M; Delgado J; Carrillo-Carrasco N; Kobeh LG; Ruiz A; Cervantes R; Torres AP; Cabrera N; González A; Maldonado C; Isibasi A
Mol Biochem Parasitol; 2003 Aug; 130(2):65-74. PubMed ID: 12946842
[TBL] [Abstract][Full Text] [Related]
8. Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions.
Liu D; Kebaier C; Pakpour N; Capul AA; Beverley SM; Scott P; Uzonna JE
Infect Immun; 2009 Aug; 77(8):3272-83. PubMed ID: 19487470
[TBL] [Abstract][Full Text] [Related]
9. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.
Srivastava S; Pandey SP; Jha MK; Chandel HS; Saha B
Clin Exp Immunol; 2013 Jun; 172(3):403-9. PubMed ID: 23600828
[TBL] [Abstract][Full Text] [Related]
10. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.
Späth GF; Epstein L; Leader B; Singer SM; Avila HA; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9258-63. PubMed ID: 10908670
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors.
Svárovská A; Ant TH; Seblová V; Jecná L; Beverley SM; Volf P
PLoS Negl Trop Dis; 2010 Jan; 4(1):e580. PubMed ID: 20084096
[TBL] [Abstract][Full Text] [Related]
12. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling.
de Veer MJ; Curtis JM; Baldwin TM; DiDonato JA; Sexton A; McConville MJ; Handman E; Schofield L
Eur J Immunol; 2003 Oct; 33(10):2822-31. PubMed ID: 14515266
[TBL] [Abstract][Full Text] [Related]
13.
Quintela-Carvalho G; Goicochea AMC; Mançur-Santos V; Viana SM; Luz YDS; Dias BRS; Lázaro-Souza M; Suarez M; de Oliveira CI; Saraiva EM; Brodskyn CI; Veras PT; de Menezes JPB; Andrade BB; Lima JB; Descoteaux A; Borges VM
Front Cell Infect Microbiol; 2022; 12():788196. PubMed ID: 35463648
[TBL] [Abstract][Full Text] [Related]
14. The role of phosphoglycans in Leishmania-sand fly interactions.
Sacks DL; Modi G; Rowton E; Späth G; Epstein L; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):406-11. PubMed ID: 10618431
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Properties of
Nogueira PM; de Menezes-Neto A; Borges VM; Descoteaux A; Torrecilhas AC; Xander P; Revach OY; Regev-Rudzki N; Soares RP
Front Cell Infect Microbiol; 2020; 10():380. PubMed ID: 32850481
[No Abstract] [Full Text] [Related]
16. Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern.
Dobson DE; Kamhawi S; Lawyer P; Turco SJ; Beverley SM; Sacks DL
PLoS Pathog; 2010 Nov; 6(11):e1001185. PubMed ID: 21085609
[TBL] [Abstract][Full Text] [Related]
17. Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?
Forestier CL; Gao Q; Boons GJ
Front Cell Infect Microbiol; 2014; 4():193. PubMed ID: 25653924
[TBL] [Abstract][Full Text] [Related]
18. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana.
Ilg T
EMBO J; 2000 May; 19(9):1953-62. PubMed ID: 10790362
[TBL] [Abstract][Full Text] [Related]
19. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis.
Dermine JF; Scianimanico S; Privé C; Descoteaux A; Desjardins M
Cell Microbiol; 2000 Apr; 2(2):115-26. PubMed ID: 11207568
[TBL] [Abstract][Full Text] [Related]
20. Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase.
Balaraman S; Singh VK; Tewary P; Madhubala R
Mol Biochem Parasitol; 2005 Jan; 139(1):117-27. PubMed ID: 15610826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
